Evaluating tumor characteristics and treatment response in colorectal cancer patients
Predict - a Translational Study to Predict Tumour Response to Neoadjuvant Treatment
This study is testing how different tumor features and treatments affect adults with colorectal cancer by collecting samples from their bodies to learn more about the disease.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 800 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Sahlgrenska University Hospital Academic / other |
| Locations | 1 site (Gothenburg) |
| Trial ID | NCT04130971 on ClinicalTrials.gov |
What this trial studies
This observational study involves adult patients diagnosed with colorectal cancer at Sahlgrenska University Hospital. Participants will provide tissue samples through biopsies taken during endoscopic procedures, follow-up exams, and surgeries. Blood, urine, and mouth swab samples will also be collected at various time points to assess tumor characteristics and treatment responses. The study aims to gather comprehensive biological data to better understand colorectal cancer progression and treatment efficacy.
Who should consider this trial
Good fit: Ideal candidates for this study are adults diagnosed with colorectal cancer.
Not a fit: Patients with conditions other than colorectal cancer will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved personalized treatment strategies for colorectal cancer patients.
How similar studies have performed: Similar observational studies have shown promise in understanding cancer biology and treatment responses, suggesting potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Colorectal cancer Exclusion Criteria: * Not colorectal cancer
Where this trial is running
Gothenburg
- Dept. of Surgery, Sahlgrenska University Hospital/Ostra — Gothenburg, Sweden (Recruiting)
Study contacts
- Study coordinator: Eva Angenete
- Email: eva.angenete@vgregion.se
- Phone: 0760514441
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.